Following is a look at two companies that released quarterly results this week. One is from the world of tech. The other resides in the old-economy landscape of industrial goods.

EMC (EMC) reported Q4 results on Tuesday. According to the press release, the company is doing quite well. Sales increased 17% on a sequential basis, and adjusted earnings came in at 33 cents per diluted share, an increase of over 40% compared to the previous quarter. Juxtaposing this stat with data at Earnings.com, we see that management beat projections by three pennies.

Continue reading Two Quarterly Reports: EMC and Illinois Tool Works

Two Quarterly Reports: EMC and Illinois Tool Works originally appeared on BloggingStocks on Thu, 28 Jan 2010 09:30:00 EST. Please see our terms for use of feeds.

Continue reading Illinois Tool Works (ITW) hits 52-week high on reaffirmed outlook

Illinois Tool Works (ITW) hits 52-week high on reaffirmed outlook originally appeared on BloggingStocks on Mon, 16 Nov 2009 13:20:00 EST. Please see our terms for use of feeds.

"Golf has Tiger Woods, novelists have Tom Clancy, and the investment community has stars such as Bruce Berkowitz, Bill Nygren, Charlie Dreifus, and Mario Gabelli," states Paul Tracy.

In his The Street Authority Market Advisor, he suggests, "These money managers are at the pinnacle of their craft." Here, he takes a look at these "celebrities" and some of their current top stock holdings.

"These money managers have all amassed prodigious gains over the years for their shareholders. Over the past few months, these gurus have come out with ringing endorsements for certain stocks. This isn't empty talk -- they are putting their money where their mouth is.

Continue reading Investing with the stars: Top stocks from top managers

Investing with the stars: Top stocks from top managers originally appeared on BloggingStocks on Fri, 22 May 2009 11:00:00 EST. Please see our terms for use of feeds.

• Deutsche Bank downgraded shares of Procter & Gamble (NYSE:PG) to Hold from Buy on valuation and their expectation for slowing short-term industry growth, especially in beauty.
  
• Citigroup downgraded Human Genome (NASDAQ:HGSI) to Hold from Buy as they believe giving up Syncria's royalties removes an important value driver for the stock.
  
• HSBC downgraded shares of Arcelor Mittal (NYSE:MT) to Neutral from Overweight on valuation and believes the company needs to raise prices more than costs have risen for iron ore, coking coal and steel scrap.

• BAE Systems (NASDAQ:BAESY) was cut to Equal Weight from Overweight at Morgan Stanley.
  
• Merrill downgraded Zoltek (NASDAQ:ZOLT) to Neutral from Buy.
  
• Credit Suisse downgraded Illinois Tool Works (NYSE:ITW) and International Paper (NYSE:IP) to Neutral from Outperform.

Analyst downgrades: PG, HGSI and MT originally appeared on BloggingStocks on Thu, 17 Apr 2008 11:07:00 EST. Please see our terms for use of feeds.

Continue reading Illinois Tool Works (ITW): OK despite the housing downturn

Illinois Tool Works (ITW): OK despite the housing downturn originally appeared on BloggingStocks on Mon, 19 Nov 2007 16:56:00 EST. Please see our terms for use of feeds.

There is a Glenview, Illinois company with a name that leads one to believe it's in the business of making tools . . . and it is. There is rather more to it, though. The firm actually consists of about 750 decentralized business units in 49 countries, and tools are just the beginning.

Illinois Tool Works (NYSE: ITW) is a diversified manufacturer of highly engineered components, industrial systems and consumables. The company's Engineered Products segment provides the construction, automotive and consumer durables markets with plastic and metal components, trusses, fasteners, adhesives, cross-laminated plastic films and laminate flooring products. The Specialty Systems segment designs and manufactures machinery, packaging systems, tools, welding products, electronic assembly materials, cooking equipment and related consumables. General Electric (NYSE: GE) is among the firm's major competitors.

ITW investors were pleased last week, when Merrill Lynch (NYSE: MER) upgraded the stock from "neutral" to "buy." The broker said the base business growth rate is positioned to begin to accelerate, due to easier comparisons and on-going strength from international end markets. Also, the company affirmed guidance ranges. It still sees Q2 EPS of 86-90 cents (88 cent consensus) and FY07 EPS of $3.27-$3.39 ($3.33 consensus). The stock popped into a bullish "pennant" consolidation pattern on the news. Prices frequently exit pennants moving in the same direction they were traveling when they entered them. In this case, that would be to the upside.

Continue reading Illinois Tool Works: More than just tools

Illinois Tool Works: More than just tools originally appeared on BloggingStocks on Wed, 20 Jun 2007 13:49:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Credit Suisse initiated shares of Allied Waste Industries Inc (NYSE: AW), Republic Services Inc (NYSE: RSG) and Waste Management Inc (NYSE: WMI) with Outperform ratings and a $16 target, $35 target and $45 target, respectively.
• Bernstein initiated the machinery and capital goods sector, initiating shares of Caterpillar Inc (NYSE: CAT) and Illinois Tool Works Inc (NYSE: ITW) with Outperform ratings and a $100 target and $68 target, respectively and Deere & Company (NYSE: DE), Eaton Corporation (NYSE: ETN), Ingersoll-Rand Company Ltd (NYSE: IR) and Parker-Hannifin Corporation (NYSE: PH) with Market Perform ratings.
• Sandler initiated shares of Preferred Bank Los Angeles CA (NASDAQ: PFBC) and UCBH Holdings, Inc (NASDAQ: UCBH) with Buy ratings and shares of Cathay General Bancorp (NASDAQ: CATY) and East West Bancorp, Inc (NASDAQ: EWBC) with Hold ratings.

• Golfsmith International Holdings Inc (NASDAQ: GOLF) was initiated at Wedbush with a Buy rating and $8.75 target, as the firm believes the company is an attractive growth story and buyout candidate.
• Pharmasset Inc (NASDAQ: VRUS) was initiated with a Buy rating and $12 target at Banc of America, as the firm believes Clevudine has the potential to be best in class for the treatment of the hepatitis B virus.
• Ciena Corporation (NASDAQ: CIEN) was initiated with an Outperform rating and $40 target at Piper Jaffray.

Analyst initiations 6-06-07: AW, RSG and WMI originally appeared on BloggingStocks on Wed, 06 Jun 2007 10:35:00 EST. Please see our terms for use of feeds.